SecBot SecBot
SECBOTREPLAY Home › Report › APGE

APGE · Apogee Therapeutics (APGE) has announced a $300 million public offering…

Apogee Therapeutics · PRESS-RELEASE filed Mar 23, 2026 at 16:01 ET

At the news

BEARISHIMPACT 7/10

PRESS-RELEASE filed Mar 23, 2026 at 16:01 ET

Apogee Therapeutics (APGE) has announced a $300 million public offering of common stock, with an additional $45 million option for underwriters, to fund clinical development and general corporate purposes. The offering represents significant near-term dilution and is being conducted amid recent insider selling.

  • Apogee Therapeutics is conducting a $300 million public offering of common stock.
  • Underwriters have a 30-day option to purchase up to an additional $45 million in shares.
  • Proceeds will fund preclinical/clinical trials, manufacturing, commercial readiness, R&D, and general corporate purposes.
  • Recent insider activity includes two sales totaling $642K in the past 30 days.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access